NIAID plan for in-depth tuberculosis research
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
List view / Grid view
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection...
This poster discusses a process for a 12-week clone development process. The process starts in silico, and progresses through screening and clone selection in 96-deepwell plates up to five liter shaker flasks...
Researchers have developed a highly specific apoptosis assay designed for immunofluorescence microscopy analysis of fixed core needle biopsy specimens...
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately...
This whitepaper focuses on developing biochemical assays where substrate and product are small molecules using a novel MALDI-HTS system...
21 February 2013 | By Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany
Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify…